Stephen Barat, SVP of Therapeutics at HTG Molecular Diagnostics, holds 421.00 shares in HTG Molecular Diagnostics (Ticker: HTGMQ). Most recently, Stephen Barat Sold $888 shares of HTG Molecular Diagnostics on Jun 09, 2023 for an estimated value of 710.40.